BlackRock Institutional Trust’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$2.65M Buy
36,406
+68
+0.2% +$4.42K ﹤0.01% 2963
2016
Q3
$2.17M Buy
36,338
+704
+2% +$44.8K ﹤0.01% 3016
2016
Q2
$2.25M Buy
35,634
+1,958
+6% +$126K ﹤0.01% 2994
2016
Q1
$2.11M Sell
33,676
-1,714
-5% -$101K ﹤0.01% 3017
2015
Q4
$2.07M Buy
35,390
+2,171
+7% +$123K ﹤0.01% 3109
2015
Q3
$1.79M Buy
33,219
+1,101
+3% +$60K ﹤0.01% 3153
2015
Q2
$1.92M Sell
32,118
-5,269
-14% -$297K ﹤0.01% 3135
2015
Q1
$2.24M Sell
37,387
-267
-0.7% -$15.7K ﹤0.01% 3071
2014
Q4
$2.26M Sell
37,654
-9,535
-20% -$528K ﹤0.01% 3049
2014
Q3
$2.3M Sell
47,189
-3,427
-7% -$174K ﹤0.01% 3016
2014
Q2
$2.6M Buy
50,616
+12,271
+32% +$630K ﹤0.01% 3076
2014
Q1
$2.22M Sell
38,345
-1,194
-3% -$65.2K ﹤0.01% 3128
2013
Q4
$2.26M Sell
39,539
-3,999
-9% -$219K ﹤0.01% 3109
2013
Q3
$2.59M Sell
43,538
-1,490
-3% -$81.3K ﹤0.01% 3007
2013
Q2
$2.44M Buy
+45,028
New +$2.12M ﹤0.01% 2993

Other funds holding UTMD

BlackRock Institutional Trust's UTMD Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Utah Medical Products (UTMD) stake by 0.19% in Q4 2016, buying an estimated $4.42K and bringing the position to 36,406 shares worth $2.65M. The position accounts for ﹤0.01% of the portfolio, ranked #2963.

BlackRock Institutional Trust first reported a position in UTMD in Q2 2013 and has held it in 15 quarters since. 75 funds tracked by Wall St. Rank hold UTMD as of Q4 2016.

  • BlackRock Institutional Trust held 36,406 shares of Utah Medical Products worth $2.65M as of Q4 2016.
  • BlackRock Institutional Trust bought 68 Utah Medical Products shares in Q4 2016, an estimated $4.42K.
  • Utah Medical Products made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2963 holding.
  • BlackRock Institutional Trust first reported a position in Utah Medical Products in Q2 2013 and has held it in 15 quarters since.
  • 75 funds tracked by Wall St. Rank held Utah Medical Products as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.